Succinylcholine: Difference between revisions

No edit summary
Line 1: Line 1:
== Contraindications ==
''See [[critical care quick reference]] for drug doses by weight.''
#Hyperkalemia
 
#Preexisting hyperkalemia
==General==
#Burns >5d old
*Type:
#Crush injury >5d old
*Dosage Forms:
#Severe infection >5d old
*Common Trade Names:
#Neuromuscular diseases (e.g. Myasthenia Gravis), myopathies
 
#History of [[Malignant Hyperthermia]]
==Adult Dosing==
 
==Pediatric Dosing==
 
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
*Lactation:
*Renal Dosing
**Adult
**Pediatric
*Hepatic Dosing
**Adult
**Pediatric
 
==Contraindications==
*Hyperkalemia
*Preexisting hyperkalemia
*Burns >5d old
*Crush injury >5d old
*Severe infection >5d old
*Neuromuscular diseases (e.g. Myasthenia Gravis), myopathies
*History of [[Malignant Hyperthermia]]
*Allergy to class/drug
 
==Adverse Reactions==
===Serious===
 
===Common===
 
==Pharmacology==
*Half-life:
*Metabolism:
*Excretion:
*Mechanism of Action:


==See Also==
==See Also==
Line 12: Line 45:
*[[Critical care quick reference]]
*[[Critical care quick reference]]


==Source==
==Sources==
*Tintinalli
*Levitan, R. Annals of EM. Vol 45, Issue 2. Safety of succinylcholine in myasthenia gravis.
*Levitan, R. Annals of EM. Vol 45, Issue 2. Safety of succinylcholine in myasthenia gravis.
<references/>


[[Category:Drugs]]
[[Category:Drugs]]
[[Category:Airway/Resus]]

Revision as of 03:01, 24 February 2015

See critical care quick reference for drug doses by weight.

General

  • Type:
  • Dosage Forms:
  • Common Trade Names:

Adult Dosing

Pediatric Dosing

Special Populations

  • Pregnancy Rating:
  • Lactation:
  • Renal Dosing
    • Adult
    • Pediatric
  • Hepatic Dosing
    • Adult
    • Pediatric

Contraindications

  • Hyperkalemia
  • Preexisting hyperkalemia
  • Burns >5d old
  • Crush injury >5d old
  • Severe infection >5d old
  • Neuromuscular diseases (e.g. Myasthenia Gravis), myopathies
  • History of Malignant Hyperthermia
  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

See Also

Sources

  • Levitan, R. Annals of EM. Vol 45, Issue 2. Safety of succinylcholine in myasthenia gravis.